AOA releases mobile game to educate gamers about eye health

Article

The American Optometric Association (AOA) released a mobile board game, Blink Land, which aims to teach users healthier eye care practices.

Blink Land provides gamers with the opportunity to adopt healthy eye habits by sharing tangible actions players can take to protect their eyes.

(Adobe.Stock/MixandMatchStudios)

On June 15, 2023, the American Optometric Association (AOA) released a mobile board game, Blink Land, to teach its players about eye health in relation to screen time. Eye Deserve More, AOA’s public awareness campaign, launched this game as a way to demonstrate how gaming and eye health can go together.1

Many gamers know that screen time has detrimental effects on their vision, but despite this, many gamers do not visit a health care professional for an eye exam every year. Research has shown that prolonged screen time, something gamers are frequently exposed to, often result in eye strain, headaches, dry eyes, and blurred vision. These negative side effects are due to a decreased blink rate while viewing screens.

Blink Land provides gamers with the opportunity to adopt healthy eye habits by sharing tangible actions players can take to protect their eyes. By following the hero character “Blink,” players learn how to maintain eye health by using the 20-20-20 rule, blinking frequently, and setting up screens properly. Blink Land will also educate players on how screen time and eye health are related through facts, trivia, and minigames.

“As someone who has experienced the impact long hours on screens has on my eyes, I felt passionate about developing Blink Land, which incorporates eye health into every aspect of the game” said Elaine Gómez-Sanchez, game designer and developer of Blink Land, in a press release. “With the popularity of gaming on the rise, we should all ensure we are taking proper care of our eye health so we can continue doing all that we love on screens for years to come.”

Blink Land is visible on both Apple and Android devices.

References
  1. The American Optometric Association launches first ever eye-friendly mobile board game, Blink Land. News release. June 15, 2023. Accessed June 16, 2023. https://www.aoa.org/about-the-aoa/press-room/press-releases/the-american-optometric-association-launches-first-ever-eye-friendly-mobile-board-game-blink-land?sso=y
Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.